1 / 6

Rapid Acting Insulin Market Share PPT

the growth of the global rapid acting insulin market is driven by increase in prevalence of diabetes, surge in geriatric population who are susceptible to develop diabetes, and surge in adoption of sedentary lifestyle. These factors contribute to the growth of the industry during the forecast period

Millerpeet
Download Presentation

Rapid Acting Insulin Market Share PPT

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Rapid Acting Insulin Market 

  2. Rapid Acting Insulin Market to Garner $8.92 Bn, Globally, by 2027 at 4.1% CAGR: Allied Market Research The growth of the global rapid acting insulin market is driven by increase in prevalence of diabetes, surge in geriatric population who are susceptible to develop diabetes, and surge in adoption of sedentary lifestyle. These factors contribute to the growth of the industry during the forecast period. Rise in availability of continuous glucose monitoring, surge in investments in R&D for human recombinant insulin, and increase in government expenditure on healthcare drive the growth of the global rapid acting insulin market. However, adverse effects associated with use of rapid acting insulin hinder the market growth. On the contrary, undiagnosed population in developing region is estimated to open lucrative opportunities for market players in the future.

  3. Covid-19 Scenario: • The patients suffering from respiratory diseases and diabetes are at higher risk of getting infected by Covid-19 virus. Thus, the demand for rapid acting insulin has increased during the pandemic. • However, the prolonged lockdown across various countries have disrupted the supply chain and increased the prices of raw materials. • The pandemic and restriction on international trade has created challenges for manufacturing and distribution of rapid acting insulin. Covid-19 scenario: Download Free Sample Report at: https://www.alliedmarketresearch.com/request-sample/10964

  4. List of key players profiled in the report: • Biocon Limited • ADOCIA SAS • Gan & Lee Pharmaceuticals • Eli Lilly and Company • Mannkind Corporation • Geropharm LLC • Sanofi S.A. • Novo Nordisk A/S • Wockhadt Ltd.

  5. Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry. ABOUT US Allied Market Research (AMR)is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry. Contact: David Correa 5933 NE Win Sivers Drive#205, Portland, OR 97220 United States, USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141, UK: +44-845-528-1300, Hong Kong: +852-301-84916, India (Pune) help@alliedmarketresearch.com Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

  6. THANK YOU

More Related